| For: | Xu YH, Zhu WM, Guo Z. Current status of novel biologics and small molecule drugs in the individualized treatment of inflammatory bowel disease. World J Gastroenterol 2022; 28(48): 6888-6899 [PMID: 36632311 DOI: 10.3748/wjg.v28.i48.6888] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i48/6888.htm |
| Number | Citing Articles |
| 1 |
Małgorzata Godala, Ewelina Gaszyńska, Konrad Walczak, Ewa Małecka-Wojciesko. Role of Serum Interleukin-6, Interleukin-1β and Interleukin-10 in Assessment of Disease Activity and Nutritional Status in Patients with Inflammatory Bowel Disease. Journal of Clinical Medicine 2023; 12(18) doi: 10.3390/jcm12185956
|
| 2 |
Mohamed Tausif Siddiqui, Rhytha Kasiraj, Maliha Naseer. Medical Management of Ulcerative Colitis and Crohn’s Disease—Strategies for Inducing and Maintaining Remission. Surgical Clinics of North America 2025; 105(2) doi: 10.1016/j.suc.2024.10.007
|
| 3 |
Mikołaj Bugajewski, Norbert Angerhoefer, Leszek Pączek, Beata Kaleta. Lentinula edodes as a Source of Bioactive Compounds with Therapeutical Potential in Intestinal Inflammation and Colorectal Cancer. International Journal of Molecular Sciences 2025; 26(7) doi: 10.3390/ijms26073320
|
| 4 |
Daopo Lin, Yang Jin, Xiaoxiao Shao, Yuan Xu, Guolong Ma, Yi Jiang, Yinghe Xu, Yongpo Jiang, Dingyuan Hu. Global, regional, and national burden of inflammatory bowel disease, 1990–2021: Insights from the global burden of disease 2021. International Journal of Colorectal Disease 2024; 39(1) doi: 10.1007/s00384-024-04711-x
|
| 5 |
Ahmed Aljabri, Ghareb M. Soliman, Yasmin N. Ramadan, Mohammed A. Medhat, Helal F. Hetta. Biosimilars versus biological therapy in inflammatory bowel disease: challenges and targeting strategies using drug delivery systems. Clinical and Experimental Medicine 2025; 25(1) doi: 10.1007/s10238-025-01558-6
|
| 6 |
J. Ben Shimol. Perimenopause in women with rheumatologic diseases: a spotlight on an under-addressed transition. Climacteric 2024; 27(2) doi: 10.1080/13697137.2023.2276201
|
| 7 |
Tao Xie, Gao-Yao Cao, Shize Zhang, Meng-Ke Li, Xin Jin, Liu Liu, Guangji Wang, Le Zhen. Discovery of Thiazole Carboxamides as Novel Vanin-1 Inhibitors for Inflammatory Bowel Disease Treatment. Journal of Medicinal Chemistry 2024; 67(22) doi: 10.1021/acs.jmedchem.4c01838
|
| 8 |
Inmaculada Serrano, Ana Luque, Alexandra Ruiz-Cerulla, Sergio Navas, Anna M. Blom, Santiago Rodríguez de Córdoba, Francisco J. Fernández, M. Cristina Vega, Francisco Rodríguez-Moranta, Jordi Guardiola, Josep M. Aran. C4BP(β-)-mediated immunomodulation attenuates inflammation in DSS-induced murine colitis and in myeloid cells from IBD patients. Pharmacological Research 2023; 197 doi: 10.1016/j.phrs.2023.106948
|
| 9 |
Satyam K. Ghodasara, Kristine M. Hauser, Kaitlyn M. Oldewurtel, Rolando H. Rolandelli, Zoltan H. Nemeth. A Comparison of Clinical Outcomes of Colectomies for Pediatric and Adult Patients With Inflammatory Bowel Disease. The American Surgeon™ 2024; 90(11) doi: 10.1177/00031348241256066
|
| 10 |
Hoor AlKaabi, Siham AlSinani, Mohamed El-Kassas, Khalid A. Alswat, Khalid M. AlNaamani. Hepatitis C Direct-Acting Antivirals in the Immunosuppressed Host: Mechanisms, Interactions, and Clinical Outcomes. Viruses 2025; 17(11) doi: 10.3390/v17111422
|
| 11 |
Mengmeng Jie, Qiushi Liao, Cheng Liu. Crosstalk between circRNAs and the classic signaling pathways in IBD. RNA Biology 2026; 23(1) doi: 10.1080/15476286.2026.2684781
|
| 12 |
Shangyong Zuo, Kefan Li, Liang Feng, Xingyan Yu, Yifan Wang, Chengwei Wu, Wenjian Weng, Yaoting He, Xiujun Cai, Kui Cheng. Visual theranostic oral nanozymes for IBD from principles to preclinical design. Bioactive Materials 2026; 65 doi: 10.1016/j.bioactmat.2026.06.002
|
| 13 |
Bailu Geng, Congmin Zhu, Zilu Cui, Yiqian Chen, Qian Zhang, Haiyun Shi, Li Min, Shengtao Zhu, Weizhen Zhang, Mengran Zhao, Shutian Zhang, Junxuan Xu. Maslinic acid alleviates ulcerative colitis by inhibiting the colitis-aggravating pathogen Clostridium perfringens and modulating gut microbiota. Phytomedicine 2025; 146 doi: 10.1016/j.phymed.2025.157144
|
| 14 |
Mojahid Mohammed Khalid Elnur, Kiran Yadav, Kalpana Ghimire, Prakash Chaudhary, Dong-Young Choi, Jung-Ae Kim, Byeong-Seon Jeong. Design, synthesis, and biological evaluation of clovamide analogues as anti-colitis agents modulating NF-κB/STAT3/iNOS signaling. Bioorganic Chemistry 2026; 180 doi: 10.1016/j.bioorg.2026.110097
|
| 15 |
Chao Nie, Yunyi Zhao, Pengjie Wang, Ran Wang, Yixuan Li, Xifan Wang, Bing Fang, Xiaoyu Wang, Jing Zhan, Longjiao Zhu, Chong Chen, Weibo Zhang, Haiping Liao, Rong Liu. Momordica charantia Polysaccharide intervention ameliorates the symptoms of dextran sulfate sodium (DSS)-induced colitis by modulating gut microbiota and inhibiting inflammation. Journal of Functional Foods 2024; 112 doi: 10.1016/j.jff.2023.105970
|
| 16 |
John K. Giju, Subin John, Amrutha Sivadas, Meera Prabhakar, Krishnakripa K., Damu Sunilkumar, Bipin G. Nair, Sanjay Pal, Vidhya Prakash. From dysbiosis to precision medicine: targeting the microbial–metabolic axis in IBD management. Frontiers in Cellular and Infection Microbiology 2026; 16 doi: 10.3389/fcimb.2026.1826972
|
| 17 |
Sidhartha Jyoti Bora, Soubhik Bhattacharyya, Soumya Deb, Dhrubajyoti Sarkar. Phytochemicals as potential therapeutic agents for inflammatory bowel disease: a comprehensive review. Phytochemistry Reviews 2026; 25(2) doi: 10.1007/s11101-025-10188-5
|
| 18 |
Giorgia Pellegrini, Andrea Spini, Chiara Bellitto, Luca L’Abbate, Ylenia Ingrasciotta, Federica Soardo, Olivia Leoni, Arianna Mazzone, Domenica Ancona, Paolo Stella, Anna Cavazzana, Angela Scapin, Sara Lopes, Valeria Belleudi, Stefano Ledda, Paolo Carta, Paola Rossi, Lucian Ejlli, Ester Sapigni, Aurora Puccini, Rita Francesca Scarpelli, Giovambattista De Sarro, Marco Tuccori, Rosa Gini, Alessandra Allotta, Sebastiano Addario Pollina, Roberto Da Cas, Giampaolo Bucaneve, Antea Maria Pia Mangano, Francesco Balducci, Carla Sorrentino, Ilenia Senesi, Francesca Futura Bernardi, Ugo Trama, Stefania Spila Alegiani, Flavia Mayer, Marco Massari, Edoardo Vincenzo Savarino, Angela Variola, Gianluca Trifirò. Single and multiple switches, swap and retransitioning among 28,073 biological drug users with inflammatory bowel diseases: results from the Italian VALORE network. Therapeutic Advances in Gastroenterology 2025; 18 doi: 10.1177/17562848251378080
|
| 19 |
Annalisa Di Rienzo, Lisa Marinelli, Marilisa Pia Dimmito, Eleonora Chiara Toto, Antonio Di Stefano, Ivana Cacciatore. Advancements in Inflammatory Bowel Disease Management: From Traditional Treatments to Monoclonal Antibodies and Future Drug Delivery Systems. Pharmaceutics 2024; 16(9) doi: 10.3390/pharmaceutics16091185
|
| 20 |
Daniel Schweckendiek, Gerhard Rogler. Antibodies Targeting the Tumor Necrosis Factor-Like Ligand 1A in Inflammatory Bowel Disease: A New Kid on the (Biologics) Block?. Digestion 2024; 105(6) doi: 10.1159/000540421
|
| 21 |
Recent advances in the therapeutics and modes of action of a range of agents used to treat ulcerative colitis and related inflammatory conditions. Inflammopharmacology 2025; 33(9) doi: 10.1007/s10787-025-01906-8
|
| 22 |
Shi-Yan Zhang. Navigating new horizons in inflammatory bowel disease: Integrative approaches and innovations. World Journal of Gastroenterology 2024; 30(41): 4411-4416 doi: 10.3748/wjg.v30.i41.4411
|
| 23 |
Mohamed Mahmoud Hafez, Ibrahim Halil Bahcecioglu, Mehmet Yalniz, Karim Abdelwahab Kouta, Ahmed Tawheed. Future of inflammatory bowel disease treatment: A review of novel treatments beyond guidelines. World Journal of Methodology 2025; 15(4): 107643 doi: 10.5662/wjm.v15.i4.107643
|
| 24 |
Xiaoya Liang, Xin Yu, Yilin Liu, Xinghui He, Keyi Ding, Xiao Tan, Qi Li, Ting Zhao, Yue Lan, Meiling Zhou, Chunhong Li. NIR-controlled photothermal intelligent nanozyme synergizes catalysis and gas therapy for multidimensional treatment of inflammatory bowel disease. Journal of Nanobiotechnology 2025; 23(1) doi: 10.1186/s12951-025-03878-x
|
| 25 |
Victor O Adedara, Charles A Adedara, Nicola D Ruth, Grant U Alozie, Nate Nettagul. Advancements in the Management of Pediatric and Adult Inflammatory Bowel Disease: A Systematic Review of Treatment Strategies and Long-Term Outcomes. Cureus 2024; doi: 10.7759/cureus.72324
|
| 26 |
Laura Arosa, Miguel Camba-Gómez, Olga Golubnitschaja, Javier Conde-Aranda. Predictive, preventive and personalised approach as a conceptual and technological innovation in primary and secondary care of inflammatory bowel disease benefiting affected individuals and populations. EPMA Journal 2024; 15(1) doi: 10.1007/s13167-024-00351-x
|
| 27 |
Ali Alipouriani, Kamil Erozkan, Lukas Schabl, Himani Sancheti, Shaji Sebastian, Serre-Yu Wong, Phil Tozer, Benjamin L Cohen, Stefan D Holubar. TOpClass Class 4 Perineal Crohn’s Disease: A Systematic Review and Meta-analysis of Perineal Wound Complication After Proctectomy in Crohn’s Patients. Inflammatory Bowel Diseases 2025; 31(4) doi: 10.1093/ibd/izae198
|
| 28 |
Wei-Wei Dong, Tao Liu, Li-Xia He, Wen-Ting He. Targeting pyroptosis in inflammatory bowel disease: A potentially effective therapeutic approach. World Journal of Gastroenterology 2025; 31(43): 111358 doi: 10.3748/wjg.v31.i43.111358
|